TVTX
Travere TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
TVTX vs peer average
36/100
TVTX vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 3 · D 1 · F 2
Graded peers loaded
Coverage
9 graded
90% of tracked
Peer overview
TARS is the first available peer comparator.
Tarsus is a same-cap biotech/commercial launch comparator rather than a direct kidney-disease peer; useful for event-driven commercial-execution sentiment, but weak for indication-specific valuation read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TVTX
Travere Therapeutics
TARS
Tarsus
Grade
D
C
Momentum
87
91
Value
57
49
Sentiment
26
60
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs TARS
TVTX / TARS
Grade Position
Below peers
TVTX vs. peer average (D vs. C)
36/100
Momentum
87
TARSValue
57
TVTXSentiment
26
TARSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TVTX
TARS is the first peer returned for this comparison set.